PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.10%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-71.83%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-94.29%
Negative EBIT growth while JHX is at 386.17%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-94.29%
Negative operating income growth while JHX is at 123.19%. Joel Greenblatt would press for urgent turnaround measures.
-3.10%
Negative net income growth while JHX stands at 43.58%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-15.19%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-16.04%
Reduced diluted shares while JHX is at 0.12%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
149.10%
10Y revenue/share CAGR 1.25-1.5x JHX's 117.83%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
105.98%
5Y revenue/share CAGR above 1.5x JHX's 48.10%. David Dodd would look for consistent product or market expansions fueling outperformance.
24.90%
Positive 3Y CAGR while JHX is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
71.23%
Net income/share CAGR above 1.5x JHX's 8.17% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
24.53%
Below 50% of JHX's 586.41%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-37.74%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.